Skip to content
Visit specialist site
Non-clinical specialist

Chris Mirabile

Founder & CEO, NOVOS Labs · NOVOS LabsLongevity company operations, DTC longevity products, longevity self-experimentation

NOVOS founder and CEO building a DTC longevity company around the 12 hallmarks of aging

At a glance

Languages
English

Practice

About

Chris Mirabile is the Founder and CEO of NOVOS Labs, a New York Public Benefit Corporation selling longevity supplements and NOVOS Age testing. His background is entrepreneurship: he graduated from NYU Stern, won its Business Plan Competition for Hotlist, and later built NOVOS around the 12 hallmarks of aging. His personal longevity story is part of the company narrative, including a teenage brain-tumor experience and ongoing public tracking on SlowMyAge.com, where he reports a DunedinPACE pace-of-aging score of 0.69.

Approach

Signature approach

Mirabile's NOVOS role combines operator discipline, personal self-tracking, and advisory-board curation. He built the company around the 12 hallmarks of aging, brought in academic and medical advisors, and uses his own biological-age tracking as part of the public company story. The useful read is founder context: why NOVOS exists, how its supplement-and-testing stack is positioned, and how the company frames consumer longevity.

What sets them apart

  • Public-benefit company builder. NOVOS is structured as a Public Benefit Corporation and publishes extensive longevity education alongside its product line.
  • Advisory-board curation. Mirabile assembled a scientific bench that includes George Church, Matt Kaeberlein, J. Pedro Magalhães, Pamela Maher, and others.
  • Personal tracking narrative. His SlowMyAge.com results and 0.69 DunedinPACE pace-of-aging claim give the company a founder-led self-experimentation story.
  • Prior operator experience. Hotlist gives him a consumer-tech background before the longevity chapter.

Training

Education

  • Finance, Accounting, and International Business
    New York University, Stern School of Business

Elsewhere

Media and talks

Collaboration

  • Dr. George Church, PhD
    NOVOS Scientific & Medical Advisory Board — Harvard Medical School & MIT; synthetic biology and personalized genomics
  • Dr. Matt Kaeberlein, PhD
    NOVOS Scientific Advisory Board (Consultant) — University of Washington; basic mechanisms of aging and healthspan
  • Dr. J. Pedro Magalhães, PhD
    NOVOS Scientific & Medical Advisory Board — University of Liverpool / Birmingham; integrative genomics of aging
  • Dr. Pamela Maher, PhD
    NOVOS Scientific & Medical Advisory Board — Salk Institute; flavonoid neuroprotection and geroneuroprotectors
  • Kris Verburgh, MD
    NOVOS Co-Founder; Belgian physician, longevity research, author of The Longevity Code
  • Diogo Barardo, PhD
    NOVOS Head of R&D; longevity researcher and creator of DrugAge

Verification

Profile updated
Affiliations verified

Primary sourcehttps://novoslabs.com/scientists/

Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.